NORGINE WELCOMES NEW GENERAL MANAGER FOR GERMANY
AMSTERDAM, The Netherlands. 20th January 2020, 12:00 BST / CET. Norgine B.V. (Norgine) today announced that Dr Michael Lange has been appointed as General Manager Germany with effect from 15th January 2020.
Michael Lange joins Norgine from Celgene and Amgen respectively, where he worked for a short time after the sale of the psoriasis Business Unit. At Celgene he most recently worked as Business Unit Director Immunology and Inflammation in Germany.
He was leading a business turnaround for a psoriasis product and in launch preparation for a multiple sclerosis (MS) product, before Celgene's acquisition by Bristol-Myers Squibb.
During his career, Michael has held a number of increasingly senior roles in sales, marketing, medical affairs and market access with several pharmaceutical companies including Aventis Pharma, AstraZeneca and GlaxoSmithKline.
He has spent most of his working life in Germany but also many years in the United States and the UK.
Editor Details
-
Company:
- Norgine B.V.
-
Name:
- Norgine B.V.
